Skip to main content

A Review of the Global Healthcare Simulation Economy

The full content of this page is available to users only after login from the link

In February 2022, researchers from Seattle Children’s Hospital and the University of Washington School of Medicine took an in-depth look at health simulation, its economic impact, and significant hurdles to its widespread acceptance. The full manuscript, written by Taylor Sawyer, Megan M. Gray, and Rachel Umoren, is available on the Cureus website. Below is a summary of their findings.

An expanding area of healthcare involves simulation, a technique that allows for improved practice, learning, evaluation, or understanding of human actions or systems without endangering real-life patients. The benefits of healthcare simulation include improvements in patient clinical care and outcome, leading to its rapid growth over the last decade.

The review by Sawyer et al. predicts a continued expansion of the global healthcare simulation market’s products and services. A 2019 estimate of the worldwide healthcare simulation market placed its value between $1.42 to 2.27 billion, while the market is projected to reach $3.19 to $7.7 billion by 2027.